KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Equity Income (2016 - 2025)

Historic Equity Income for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to $200000.0.

  • Evolent Health's Equity Income rose 10897.26% to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $563000.0, marking a year-over-year increase of 11553.96%. This contributed to the annual value of -$3.4 million for FY2024, which is 36469.23% down from last year.
  • As of Q3 2025, Evolent Health's Equity Income stood at $200000.0, which was up 10897.26% from $200000.0 recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Equity Income peaked at $7.8 million during Q1 2021, and registered a low of -$2.2 million during Q3 2024.
  • For the 5-year period, Evolent Health's Equity Income averaged around $899888.9, with its median value being $364500.0 (2023).
  • As far as peak fluctuations go, Evolent Health's Equity Income skyrocketed by 199320.39% in 2021, and later crashed by 95000.0% in 2024.
  • Evolent Health's Equity Income (Quarter) stood at $475000.0 in 2021, then skyrocketed by 38.95% to $660000.0 in 2022, then rose by 6.06% to $700000.0 in 2023, then crashed by 74.0% to $182000.0 in 2024, then rose by 9.89% to $200000.0 in 2025.
  • Its last three reported values are $200000.0 in Q3 2025, $200000.0 for Q2 2025, and -$19000.0 during Q1 2025.